Christopher Carlsten
- Late-breaking abstract: Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting the allergen-induced early asthmatic responseBy Gail M. Gauvreau, Louis-Philippe Boulet, Richard Leigh, Donald W. Cockcroft, Beth E. Davis, Irvin Mayers, J Mark FitzGerald, Barbro Dahlen, Richard M. Watson, Joanne Milot, Veronica Swystun, Linda Hui, Ann-Sofie Lantz, Miranda Bowen, Jonathan Arm, Suzzane Maahs, Karin Meiser, Philip Lowe, Andrej Skerjanec, Christopher Carlsten, Karin Strandberg, Kieran J. Killian, Michele Laviolette, Anton Drollmann and Paul M. O'ByrneGail M. Gauvreau1Department of Medicine, McMaster University, Hamilton, ON, CanadaLouis-Philippe Boulet2Department of Medicine, Université Laval, Québec, QC, CanadaRichard Leigh3Medicine and Physiology and Pharmacology, University of Calgary, Calgary, AB, CanadaDonald W. Cockcroft4Department of Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, SK, CanadaBeth E. Davis4Department of Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, SK, CanadaIrvin Mayers5Department of Medicine, University of Alberta, Edmonton, AB, CanadaJ Mark FitzGerald6Department of Medicine, University of British Columbia, Vancouver, BC, CanadaBarbro Dahlen7Karolinska Institutet (KI), Department of Medicine, Karolinska University, Stockholm, SwedenRichard M. Watson1Department of Medicine, McMaster University, Hamilton, ON, CanadaJoanne Milot2Department of Medicine, Université Laval, Québec, QC, CanadaVeronica Swystun3Medicine and Physiology and Pharmacology, University of Calgary, Calgary, AB, CanadaLinda Hui6Department of Medicine, University of British Columbia, Vancouver, BC, CanadaAnn-Sofie Lantz7Karolinska Institutet (KI), Department of Medicine, Karolinska University, Stockholm, SwedenMiranda Bowen5Department of Medicine, University of Alberta, Edmonton, AB, CanadaJonathan Arm8Novartis Institutes for Biomedical Research, Novartis, Basel, SwitzerlandSuzzane Maahs9Novartis Institutes for Biomedical Research, Novartis, East Hanover, NJ,Karin Meiser10Integrated Information Sciences, Novartis Pharma AG, Basel, SwitzerlandPhilip Lowe10Integrated Information Sciences, Novartis Pharma AG, Basel, SwitzerlandAndrej Skerjanec8Novartis Institutes for Biomedical Research, Novartis, Basel, SwitzerlandChristopher Carlsten6Department of Medicine, University of British Columbia, Vancouver, BC, CanadaKarin Strandberg7Karolinska Institutet (KI), Department of Medicine, Karolinska University, Stockholm, SwedenKieran J. Killian1Department of Medicine, McMaster University, Hamilton, ON, CanadaMichele Laviolette2Department of Medicine, Université Laval, Québec, QC, CanadaAnton Drollmann8Novartis Institutes for Biomedical Research, Novartis, Basel, SwitzerlandPaul M. O'Byrne1Department of Medicine, McMaster University, Hamilton, ON, Canada
- Associations between the 17q21 region and allergic rhinitis in five birth cohortsBy Elaine Fuertes, Cilla Söderhäll, Nathalie Acevedo, Allan Becker, Michael Brauer, Moira Chan-Yeung, F. Nicole Dijk, Joachim Heinrich, Gerard Koppelman, Dirkje Postma, Juha Kere, Anita Kozyrskyj, Göran Pershagen, Andrew Sandford, Marie Standl, Carla Tiesler, Melanie Waldenberger, Marit Westman, Christopher Carlsten and Erik MelénElaine Fuertes1School of Population and Public Health, University of British Columbia, Vancouver, Canada2Institute Epidemiology I, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, GermanyCilla Söderhäll3Department of Biosciences and Nutrition, and Center for Biotechnology, Karolinska Institutet, Stockholm, SwedenNathalie Acevedo4Department of Medicine Solna, Translational Immunology Unit, Karolinska Institutet, Stockholm, SwedenAllan Becker5Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, CanadaMichael Brauer1School of Population and Public Health, University of British Columbia, Vancouver, Canada6Department of Medicine, University of British Columbia, Vancouver, CanadaMoira Chan-Yeung6Department of Medicine, University of British Columbia, Vancouver, CanadaF. Nicole Dijk7University Medical Center Groningen, Beatrix Children's Hospital, Pediatric Pulmonology and Pediatric Allergology, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, NetherlandsJoachim Heinrich2Institute Epidemiology I, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, GermanyGerard Koppelman7University Medical Center Groningen, Beatrix Children's Hospital, Pediatric Pulmonology and Pediatric Allergology, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, NetherlandsDirkje Postma8University Medical Center Groningen, Department of Pulmonology , Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, NetherlandsJuha Kere3Department of Biosciences and Nutrition, and Center for Biotechnology, Karolinska Institutet, Stockholm, Sweden9Folkhälsan Institute of Genetics, University of Helsinki, Helsinki, Finland10Molecular Neurology Research Program, University of Helsinki, Helsinki, FinlandAnita Kozyrskyj11Department of Pediatrics, Faculty of Medicine & Dentistry, Women and Children’s Health Research Institute, Edmonton, Canada12School of Public Health, University of Alberta, Edmonton, CanadaGöran Pershagen13Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenAndrew Sandford6Department of Medicine, University of British Columbia, Vancouver, CanadaMarie Standl2Institute Epidemiology I, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, GermanyCarla Tiesler2Institute Epidemiology I, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany14Division of Metabolic Diseases and Nutritional Medicine, Ludwig-Maximilians - University of Munich, Dr. von Hauner Children's Hospital, Munich, GermanyMelanie Waldenberger15Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Munich, Germany16Institute Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, Munich, GermanyMarit Westman17Department of Clinical Science, Intervention and Technology, Division of Ear, Nose and Throat Diseases, Karolinska Institutet, Stockholm, SwedenChristopher Carlsten1School of Population and Public Health, University of British Columbia, Vancouver, Canada6Department of Medicine, University of British Columbia, Vancouver, CanadaErik Melén13Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden18Sach's Children’s Hospital, Sach's Children’s Hospital, Stockholm, Sweden
- Diesel exhaust in asthmatics modulates leukotriene E4 and airflow through epigenetic changesBy Nathan Rabinovitch, Amrit Singh, Rui Wei Jiang, Sze Wing Wong, Scott Tebbutt and Christopher CarlstenNathan Rabinovitch1Pediatrics, National Jewish Health, Denver, CO,Amrit Singh2Medicine, University of British Columbia, Vancouver, BC, CanadaRui Wei Jiang1Pediatrics, National Jewish Health, Denver, CO,Sze Wing Wong1Pediatrics, National Jewish Health, Denver, CO,Scott Tebbutt2Medicine, University of British Columbia, Vancouver, BC, CanadaChristopher Carlsten2Medicine, University of British Columbia, Vancouver, BC, Canada
- An integrative genomics approach identifies new asthma pathways related to air pollution exposureBy Anna Gref, Simon Kebede Merid, Olena Gruzieva, Stéphane Ballereau, Allan Becker, Tom Bellander, Anna Bergström, Yohan Bossé, Matteo Bottai, Moira Chan-Yeung, Elaine Fuertes, Despo Ierodakoniou, Ruiwei Jiang, Michael S. Kobor, Michal Korek, Anita L. Kozyrskyj, Ashish Kumar, Nathanael Lemonnier, Elaina MacIntyre, David Nickle, Ma'en Obeidat, Johann Pellet, Marie Standl, Annika Sääf, Cilla Söderhäll, Carla M.T. Tiesler, Maarten Van den Berge, Judith M. Vonk, Hita Vora, Cheng-Jian Xu, Josep M. Antó, Charles Auffray, Michael Brauer, Jean Bousquet, Bert Brunekreef, W. James Gauderman, Joachim Heinrich, Juha Kere, Gerard Koppelman, Dirkje Postma, Christopher Carlsten, Göran Pershagen and Erik MelénAnna Gref1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenSimon Kebede Merid1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenOlena Gruzieva1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenStéphane Ballereau2European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, Université de Lyon, Lyon, FranceAllan Becker3Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, CanadaTom Bellander1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenAnna Bergström1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenYohan Bossé4Molecular Medicine, Laval University, Quebec, CanadaMatteo Bottai1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenMoira Chan-Yeung5Department of Medicine, University of British Columbia, Vancouver, CanadaElaine Fuertes6Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, GermanyDespo Ierodakoniou7Department of Medicine, Imperial College London, London, United KingdomRuiwei Jiang8Department of Science, University of British Columbia, Vancouver, CanadaMichael S. Kobor24Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, CanadaMichal Korek1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenAnita L. Kozyrskyj9Department of Pediatrics, University of Alberta, Edmonton, CanadaAshish Kumar1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenNathanael Lemonnier21USR 3010, Centre National de la Recherche Scientifique, Lyon, FranceElaina MacIntyre10Environmental and Occupational Health, Public Health Ontario, Toronto, CanadaDavid Nickle11Merck & Co Inc, Rahway, New Jersey, United StatesMa'en Obeidat12Centre for Heart Lung Innovation, University of British Columbia, Vancouver, CanadaJohann Pellet21USR 3010, Centre National de la Recherche Scientifique, Lyon, FranceMarie Standl6Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, GermanyAnnika Sääf1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenCilla Söderhäll13Biosciences and Nutrition, Karolinska Institutet, Stockholm, SwedenCarla M.T. Tiesler6Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, GermanyMaarten Van den Berge14Department of Pulmonology, University Medical Center Groningen, Groningen, NetherlandsJudith M. Vonk15Department of Epidemiology, University of Groningen, Groningen, NetherlandsHita Vora16Preventive Medicine, University of Southern California, Los Aneles, United StatesCheng-Jian Xu14Department of Pulmonology, University Medical Center Groningen, Groningen, NetherlandsJosep M. Antó17Respiratory Department, Centre for Research in Environmental Epidemiology, Barcelona, SpainCharles Auffray2European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, Université de Lyon, Lyon, FranceMichael Brauer18School of Population and Public Health, University of British Columbia, Vancouver, CanadaJean Bousquet19CHU Montpellier, University of Montpellier, Montpellier, FranceBert Brunekreef20Institute for Risk Assessment Sciences, Universiteit Utrecht, Utrecht, NetherlandsW. James Gauderman16Preventive Medicine, University of Southern California, Los Aneles, United StatesJoachim Heinrich6Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, GermanyJuha Kere13Biosciences and Nutrition, Karolinska Institutet, Stockholm, SwedenGerard Koppelman22Department of Pediatrics, University Medical Center Groningen, Groningen, NetherlandsDirkje Postma23Department of Pulmonary Medicine and Tuberculosis, University Medical Center Groningen, Groningen, NetherlandsChristopher Carlsten5Department of Medicine, University of British Columbia, Vancouver, CanadaGöran Pershagen1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenErik Melén1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling studyBy Gail M. Gauvreau, Louis-Philippe Boulet, Richard Leigh, Donald W. Cockcroft, Beth E. Davis, Irvin Mayers, J. Mark FitzGerald, Barbro Dahlen, R.M. Watson, Joanne Milot, Veronica Swystun, Linda Hui, Ann-Sofie Lantz, Miranda Bowen, Jonathan Arm, Suzzane Maahs, Karin Meiser, Philip Lowe, Andrej Skerjanec, Christopher Carlsten, Karin Strandberg, Kieran J. Killian, Michele Laviolette, Anton Drollmann and Paul M. O'ByrneGail M. Gauvreau1Cardio-Respiratory Lab, McMaster University, Hamilton, ON CanadaLouis-Philippe Boulet2Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC CanadaRichard Leigh3Faculty of Medicine, University of Calgary, Caldary, AB CanadaDonald W. Cockcroft4Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, SK CanadaBeth E. Davis4Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, SK CanadaIrvin Mayers5Department of Medicine, University of Alberta, Edmonton, AB CanadaJ. Mark FitzGerald6Respiratory Medicine, University of British Columbia, Vancouver, BC CanadaBarbro Dahlen7Unit of Heart and Lung Diseases, Karolinska University, Stockholm, SwedenR.M. Watson1Cardio-Respiratory Lab, McMaster University, Hamilton, ON CanadaJoanne Milot2Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC CanadaVeronica Swystun3Faculty of Medicine, University of Calgary, Caldary, AB CanadaLinda Hui6Respiratory Medicine, University of British Columbia, Vancouver, BC CanadaAnn-Sofie Lantz7Unit of Heart and Lung Diseases, Karolinska University, Stockholm, SwedenMiranda Bowen5Department of Medicine, University of Alberta, Edmonton, AB CanadaJonathan Arm8Novartis Institutes for Biomedical Research, Basel, SwitzerlandSuzzane Maahs9Novartis Institutes for Biomedical Research, East Hanover, NJ United StatesKarin Meiser10Novartis Pharma AG, Basel, SwitzerlandPhilip Lowe10Novartis Pharma AG, Basel, SwitzerlandAndrej Skerjanec10Novartis Pharma AG, Basel, SwitzerlandChristopher Carlsten6Respiratory Medicine, University of British Columbia, Vancouver, BC CanadaKarin Strandberg7Unit of Heart and Lung Diseases, Karolinska University, Stockholm, SwedenKieran J. Killian1Cardio-Respiratory Lab, McMaster University, Hamilton, ON CanadaMichele Laviolette2Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC CanadaAnton Drollmann8Novartis Institutes for Biomedical Research, Basel, SwitzerlandPaul M. O'Byrne1Cardio-Respiratory Lab, McMaster University, Hamilton, ON Canada
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.